Medacta Group SA (SWX:MOVE)
118.60
-0.60 (-0.50%)
Oct 23, 2026, 5:30 PM CEST
Medacta Group Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Medacta Group stock has a consensus rating of "Buy" and an average price target of CHF 154.98. The average 1-year stock price forecast is 30.67% higher than the current stock price, while the lowest is CHF 119.34 (+0.62%) and the highest is CHF 177.56 (+49.71%).
Price Target: CHF 154.98 (+30.67%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Sep 15, 2026.
Analyst Ratings
The average analyst rating for Medacta Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold Initiates CHF 121.00 | Hold | Initiates | CHF 121.00 | +2.02% | Sep 15, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Maintains CHF 185.00 → CHF 180.00 | Buy | Maintains | CHF 185.00 → CHF 180.00 | +51.77% | Sep 11, 2026 |
| UBS | UBS | Hold Maintains CHF 151.00 → CHF 148.00 | Hold | Maintains | CHF 151.00 → CHF 148.00 | +24.79% | Jul 21, 2026 |
Financial Forecast
Revenue This Year
760.47M
from 683.83M
Increased by 11.21%
Revenue Next Year
858.50M
from 760.47M
Increased by 12.89%
EPS This Year
4.76
from 4.33
Increased by 9.80%
EPS Next Year
5.67
from 4.76
Increased by 19.13%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.